Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcineurin Inhibitor Nephrotoxicity and Efficacy Study in Kidney Transplant Recipients
NL-OMON21129Active, not recruiting
- Start
- Sep 2000
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of cyclosporine and tacrolimus (4 arms). Primary endpoints: Best graft structure and function at 6 and 12 months, Inflammation and fibrosis on renal biopsy and 1 more. Started Sep 2000; status: active, not recruiting.
02
Drugs
cyclosporinetacrolimus
Beyond the preview
Go deeper on NL-OMON21129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21129.